Aaron YAMNIUK

Person

Vancouver BC, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies and antigen binding peptides for factor XIa inhibitors a...
- Patent number 12,065,505
- Issue date Aug 20, 2024
- Bristol-Myers Squibb Company
- Joseph M. Luettgen
- G01 - MEASURING TESTING
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,926,673
- Issue date Mar 12, 2024
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,795,231
- Issue date Oct 24, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,773,178
- Issue date Oct 3, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding antagonistic CD40 monoclonal antibodies
- Patent number 11,613,585
- Issue date Mar 28, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240239909
- Publication date Jul 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240124597
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20230322941
- Publication date Oct 12, 2023
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD3 T-Cell Engagers and Methods of Use
- Publication number 20230295310
- Publication date Sep 21, 2023
- AbCellera Biologics Inc.
- Lindsay DEVORKIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antibody Variants with Improved Pharmacokinetic Properties
- Publication number 20230203177
- Publication date Jun 29, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY
- Publication number 20230140384
- Publication date May 4, 2023
- Bristol-Myers Squibb Company
- Arvind RAJPAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES AND ANTIGEN BINDING PEPTIDES FOR FACTOR XIA INHIBITORS A...
- Publication number 20220220220
- Publication date Jul 14, 2022
- Bristol-Myers Squibb Company
- Joseph M. Luettgen
- G01 - MEASURING TESTING
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220177596
- Publication date Jun 9, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220169742
- Publication date Jun 2, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220153856
- Publication date May 19, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220144962
- Publication date May 12, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20220073636
- Publication date Mar 10, 2022
- Bristol-Myers Squibb Company
- Steven G. NADLER
- C07 - ORGANIC CHEMISTRY

Aaron YAMNIUK

Person

Patents Grantslast 30 patents

Antibodies and antigen binding peptides for factor XIa inhibitors a...

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses thereof

Antagonistic CD40 monoclonal antibodies and uses thereof

Nucleic acids encoding antagonistic CD40 monoclonal antibodies

Patents Applicationslast 30 patents

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

CD3 T-Cell Engagers and Methods of Use

Antibody Variants with Improved Pharmacokinetic Properties

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

ANTIBODIES AND ANTIGEN BINDING PEPTIDES FOR FACTOR XIA INHIBITORS A...

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L